-
Mashup Score: 3
Background: Sarcopenia, or loss of skeletal muscle mass, has been associated with poor outcomes (e.g., functional decline, increased mortality, and low quality of life), but its role in CTEPH remains unclear. The psoas muscle index (PMI) is a validated measure of sarcopenia. We investigated the incidence of sarcopenia using PMI in CTEPH. Methods: Retrospective analysis of a single-center cohort of patients with CTEPH with an available computed tomography of the abdomen and pelvis (CTAP). PMI was measured at the L3 level of the CTAP and was then calculated using the formula (left psoas area + right psoas area/height2). Patients in the first quartile of PMI were classified as sarcopenic. Results: We reviewed 558 patients with CTEPH, and 97 patients had an available CTAP before intervention. Sarcopenia was identified in 26 (24.8%) of the patients and was associated with worse baseline functional status (p = 0.008), higher mean pulmonary artery pressure (48 vs. 39 mmHg; p = 0.002), and hig
Source: www.mdpi.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
Some patients with chronic thromboembolic pulmonary hypertension (CTEPH) exhibit exercise intolerance due to reduced cardiac output (CO) even after successful balloon pulmonary angioplasty (BPA). Medical therapy is a potential option for such cases; however, it is unclear which patients necessitate it even after BPA.
Source: www.jhltonline.orgCategories: General Medicine News, CardiologistsTweet-
Increasing CO with BPA alone may be challenging in older patients with #CTEPH. Continuous adjuvant PH medication may be necessary even after successful BPA. @Hs2zK 🔗 https://t.co/X5BgXNs7SE
-
-
Mashup Score: 19Clear lungs: Rare procedure BS&W doctor learned at Mayo Clinic has Salado man breathing deeply - 1 year(s) ago
Kerry Johnson has a thing for classic cars, and for years he has spent free time tinkering with his 1964 Chevelle and 1993 Corvette. But in December of last year,
Source: www.tdtnews.comCategories: General Medicine News, CardiologistsTweet-
Great patient, great set of procedures, and great result for our cath lab and pulmonary teams bringing this treatment to CTX. #CTEPH @bswhealth_Templ @BSWHTemple_PCCM https://t.co/kfmKnCbdy9 https://t.co/xR0Kin2l0x
-
-
Mashup Score: 1
Author links open overlay panel Simone J. Dragsbaek a b, Mads D. Lyhne a c, Jacob V. Hansen a b, Christina C.E. Pedersen d, Takayuki Jujo-Sanada e f, Lina Karout g, Mannudeep K. Kalra g, Jens E. Nielsen-Kudsk a b, Asger Andersen a b Chronic thromboembolic pulmonary disease (CTEPD) with or without pulmonary hypertension (PH) at rest is a potential long-term complication from acute pulmonary embolism (PE) [1]. Unresolved clots can cause pulmonary arterial pressure increase, secondary microvasculopathy and
Source: www.sciencedirect.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Authors developed a porcine model of #ChronicThromboembolicPulmonaryDisease🐖🫁🫀Histological samples were compatible with #CTEPH patients🔬🩸 👉https://t.co/Q4PVjRC8wN @SimoneDragsbaek @MadsDam_MD @Jacob_V_Hansen @Lina_Karout1 @Nielsen_Kudsk @DocAsger @AUHCardio @AarhusUni_int https://t.co/gLiLWVG09j
-
-
Mashup Score: 1Chronic thromboembolic pulmonary hypertension: realising the potential of multimodal management - 2 year(s) ago
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare complication of acute pulmonary embolism. Important advances have enabled better understanding, characterisation, and treatment of this condition. Guidelines recommending systematic follow-up after acute pulmonary embolism, and the insight that CTEPH can mimic acute pulmonary embolism on initial presentation, have led to the definition of CTEPH imaging characteristics, the introduction of artificial intelligence diagnosis pathways, and thus the prospect of easier and earlier CTEPH diagnosis.
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
@madelcroix and colleagues describe treatment modalities targeting major vessel obstructions and microvasculopathy in chronic thromboembolic #PulmonaryHypertension, and outline a multimodal approach to management https://t.co/inoLsO3wBp #PH #CTEPH #PulmonaryEmbolism https://t.co/c9cHGYheMi
-
-
Mashup Score: 14Pulmonary Hypertension 2023 - 2 year(s) ago
The field of pulmonary hypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of therapeutic options. The five main groups of pulmonary hypertension differ in epidemiology, causes and risk factors, underlying disease mechanisms, and clinical presentation. Approaches to diagnosis and management reflect the distinctive features of each condition. In the first of a Series of three papers, Marc Humbert and colleagues provide an
Source: www.thelancet.comCategories: Latest Headlines, PulmonologyTweet-
The field of #pulmonaryhypertension has been transformed by advances in understanding of pathophysiological mechanisms and the development of a wide range of #therapeutic options Find out more in a new @LancetRespirMed Series https://t.co/ALcvKnFvoM #PH #PAH #CTEPH #COPD #ILD https://t.co/9xiHMp5yO4
-
-
Mashup Score: 0
Chronic thromboembolic pulmonary hypertension (CTEPH) is a progressive and debilitating disorder that results from incomplete resolution of vascular obstructions resulting in pulmonary hypertension. Surgical pulmonary thromboendarterectomy (PTE) is the treatment of choice for CTEPH. Unfortunately, many CTEPH patients are ineligible for PTE or do not have access to an expert surgical center.
Source: HMP Global Learning NetworkCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Effect of Combination of Balloon Pulmonary Angioplasty and Medical Therapy on Reverse Right Ventricular Remodeling and Hemodynamics in Chronic Thromboembolic Pulmonary Hypertension The authors evaluated 21 #CTEPH patients in this single-center study. https://t.co/eJMJGaHrA8 https://t.co/xrU7L3frlo
-
-
Mashup Score: 0Chronic Thromboembolic Pulmonary Vascular Disease and Left Heart Disease are not Mutually Exclusive - 2 year(s) ago
April 28, 2023 — A long-term analysis designed by Christian Gerges and Irene Lang at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary hypertension (CTEPH) also have left heart disease. In the past, the possibility of overlap between these two conditions had not been considered in the…
Source: DAICCategories: Cardiologists, Latest HeadlinesTweet-
@DAICeditor @cardiovienna Long-term analysis at the Department of Medicine II of the University Hospital Vienna and MedUni Vienna indicates that one third of patients with chronic thromboembolic pulmonary hypertension (#CTEPH) also have left #heartdisease: https://t.co/zairbu9ueF
-
-
Mashup Score: 1I’ve Reset My Priorities: Jessica’s Story - Blood Clots - 2 year(s) ago
In December 2021, I had pain, swelling, and bulging veins in my right arm. Doctors found blood clots in my subclavian and axillary veins.
Source: Blood ClotsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
"In Jan. 2020, I was diagnosed with Hodgkin’s Lymphoma at 29. After 6 brutal months of chemo, my cancer was in remission. I was ready to return to 'normal' life. But my health continued to worsen..." Read Jessica's full story: https://t.co/V8prRQEJcx #stoptheclotstory #cteph https://t.co/agXFnurxNi
-
-
Mashup Score: 2JHLT: The Podcast: Episode 27: March 2023 - 2 year(s) ago
This month’s JHLT: The Podcast is hosted by Digital Media Editor David Schibilsky, MD, who leads a discussion of two studies from the March issue of The Journal of Heart and Lung Transplantation—and the first authors who presented them. First, the editors explore a study entitled “,” which comes from Hadinnapola and colleagues at the Papworth group in Cambridge, UK. The editors welcome…
Source: thejhlt.libsyn.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Catch up on the March #JHLTThePodcast: 🧬Ang2 and hsCRP in #CTEPH/#PAH with @Charaka_H @RoyalPapworth 🫁 #EVLP and its impact on hospital costs in #LungTx with @johnpeel36 @UHNTransplant 🎧Listen on your favorite podcatcher or at https://t.co/qObbfKes5i https://t.co/0YjPBbontN
-
Sarcopenia in #CTEPH - Measuring Psoas Muscle Index as a surrogate. What did we learn? 💪🏻 👨🏼🦳🫀 ⬇️⬇️⬇️⬇️⬇️ https://t.co/BTCLUYvErN 1. Use CT abdomen and pelvis 2. Differences in PMI = differences in hemodynamics and PTE LOS 🗓️ 3. How can you make it better knowing this?